Product
Supplier
Encyclopedia
Inquiry
Home > Encyclopedia > Lisdexamfetamine dimesylate

Lisdexamfetamine dimesylate

pharmaceutical raw materials
Lisdexamfetamine dimesylate structure

Lisdexamfetamine dimesylate 

structure
  • CAS No:

    608137-33-3

  • Formula:

    C15H25N3O.2CH4O3S

  • Chemical Name:

    Lisdexamfetamine dimesylate

  • Synonyms:

    Hexanamide,2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-,(2S)-,methanesulfonate (1:2);Hexanamide,2,6-diamino-N-[(1S)-1-methyl-2-phenylethyl]-,(2S)-,dimethanesulfonate;NRP 104;Lisdexamfetamine dimesylate;Vyvanse;SPD 489;N-(L-Lysyl)-D-amphetamine dimesylate;Lisdexamphetamine dimesylate

  • Categories:

    Biochemical Engineering  >  Amino Acids and Derivatives

Description

Vyvanse is a DEA Schedule II controlled substance. Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|Lisdexamfetamine Dimesylate is the dimesylate form and prodrug of the d-isomer of amphetamine, a non-catecholamine sympathomimetic amine with central nervous system (CNS) stimulating activity. Upon administration, lisdexamphetamine is converted to dextroamphetamine through cleavage of the lysine group. Dextroamphetamine acts by facilitating the release of catecholamines, particularly noradrenaline and dopamine, from its storage sites in nerve terminals in the CNS, and inhibits their uptake within the mesocorticolimbic system, a major component of the brain reward system, resulting in measurable behavioral changes such as euphoria, mental alertness and excitement and appetite suppression. As a CNS stimulant, this agent may increase blood pressure.|A dextroamphetamine drug precursor that also functions as a CENTRAL NERVOUS SYSTEM STIMULANT and DOPAMINE UPTAKE INHIBITOR and is used in the treatment of ATTENTION DEFICIT HYPERACTIVITY DISORDER.

Lisdexamfetamine dimesylate Basic Attributes

455.58982

455.17600

200-659-6

SJT761GEGS

1205

DTXSID60209653

C76628

Characteristics

207

4.15120

488ºC at 760 mmHg

9℃

-20°C

Safety Information

UN1230 - class 3 - PG 2 - Methanol, solution

1

11-23/24/25-39/23/24/25

7-16-36/37-45

F,T

P210-P260-P280-P301 + P310-P311

H225-H301 + H311 + H331-H370

Drug Information

A loosely defined group of drugs that tend to increase behavioral alertness, agitation, or excitation. They work by a variety of mechanisms, but usually not by direct excitation of neurons. The many drugs that have such actions as side effects to their main therapeutic use are not included here. (See all compounds classified as Central Nervous System Stimulants.)|Drugs that block the transport of DOPAMINE into axon terminals or into storage vesicles within terminals. Most of the ADRENERGIC UPTAKE INHIBITORS also inhibit dopamine uptake. (See all compounds classified as Dopamine Uptake Inhibitors.)

Dimesylate, Lis-dexamfetamine

Lisdexamfetamine|Vyvanse|1205|Schedule II - Substances in the DEA Schedule II have a high potential for abuse which may lead to severe psychological or physical dependence.|No

Lisdexamfetamine dimesylate Use and Manufacturing

Uses

Treatment of atten tion deficit hyperactivity disorder (ADHD).

Human Drugs -> FDA Approved Drug Products with Therapeutic Equivalence Evaluations (Orange Book) -> Active Ingredients

Computed Properties

Molecular Weight:455.6
Hydrogen Bond Donor Count:5
Hydrogen Bond Acceptor Count:9
Rotatable Bond Count:8
Exact Mass:455.17599275
Monoisotopic Mass:455.17599275
Topological Polar Surface Area:207
Heavy Atom Count:29
Complexity:344
Defined Atom Stereocenter Count:2
Covalently-Bonded Unit Count:3
Compound Is Canonicalized:Yes

Recommended Suppliers of Lisdexamfetamine dimesylate

Scan the QR Code to Share

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.